Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Almen praktiserende læge Bettina Gregersen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.2% 6.3% 3.8% 3.3% 3.6% 4.3% 9.9% 9.9%   Credit score (0-100)   57 37 50 54 52 48 25 25   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3.0 194 198 -6.0 -20.4 -44.7 0.0 0.0   EBITDA   -58.0 133 -189 -938 -949 -953 0.0 0.0   EBIT   -58.0 133 -189 -938 -949 -953 0.0 0.0   Pre-tax profit (PTP)   552.0 744.0 850.0 486.0 780.2 702.2 0.0 0.0   Net earnings   564.0 715.0 676.0 392.0 623.1 531.4 0.0 0.0   Pre-tax profit without non-rec. items   552 744 850 486 780 702 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,914 2,229 2,505 2,497 2,620 2,752 2,127 2,127   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,927 2,267 2,668 2,692 2,812 3,041 2,127 2,127   Net Debt   -374 -2,240 -518 -696 -945 -1,332 -2,127 -2,127     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3.0 194 198 -6.0 -20.4 -44.7 0.0 0.0   Gross profit growth   -94.8% 6,366.7% 2.1% 0.0% -240.5% -118.9% 0.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,927 2,267 2,668 2,692 2,812 3,041 2,127 2,127   Balance sheet change%   15.0% 17.6% 17.7% 0.9% 4.5% 8.1% -30.1% 0.0%   Added value   -58.0 133.0 -189.0 -938.0 -949.2 -952.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -1,933.3% 68.6% -95.5% 15,633.3% 4,646.3% 2,130.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   30.8% 35.5% 34.7% 19.7% 28.3% 24.3% 0.0% 0.0%   ROI %   31.3% 36.0% 35.9% 20.8% 30.0% 25.9% 0.0% 0.0%   ROE %   31.9% 34.5% 28.6% 15.7% 24.4% 19.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   99.3% 98.3% 93.9% 92.8% 93.2% 90.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   644.8% -1,684.2% 274.1% 74.2% 99.5% 139.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   30.0 59.6 3.8 5.1 6.7 5.8 0.0 0.0   Current Ratio   30.0 59.6 3.8 5.1 6.7 5.8 0.0 0.0   Cash and cash equivalent   374.0 2,240.0 518.0 696.0 944.6 1,332.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   377.0 2,228.0 172.0 464.0 610.4 674.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -58 133 -189 -938 -949 -953 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -58 133 -189 -938 -949 -953 0 0   EBIT / employee   -58 133 -189 -938 -949 -953 0 0   Net earnings / employee   564 715 676 392 623 531 0 0